好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Multidisciplinary approach to Patent Foramen Ovale (PFO) closure for Cryptogenic Stroke: Brain-Heart Board Experience
Cerebrovascular Disease and Interventional Neurology
P11 - Poster Session 11 (11:45 AM-12:45 PM)
6-024
Our study evaluates the predictors of closure recommendation by multidisciplinary board for PFO closure and its impact on outcomes.
PFO closure in carefully selected patients is an effective secondary preventive strategy in young cryptogenic stroke patients which requires close collaborative approach.

Brain-Heart Board is comprised of vascular neurology and cardiology subspecialities. Adult patients referred to the board for consideration of PFO closure between October 2017 to March 2021 were included in this analysis. Demographics, comorbid conditions, infarct location, Risk of Paradoxical Embolism (RoPE) Score, event frequencies (recurrent TIA or stroke, intracranial hemorrhage (ICH), post-PFO closure cardiac arrythmias) and modified Rankin Scale (mRS at 1 year) were compared between the groups (PFO closure vs. medical management). Multivariable logistic regression was used to identify predictors of closure and chi-square tests to test differences in outcomes for patients according to management.   

270 patients (229 stroke; 41 TIA) were included in the analysis. 119 (44%) patients were recommended for PFO closure of which 117 (98%) had infarct on neuroimaging. Age and RoPE score were similar in closure and medical management cohorts (age; 50±12 vs. 52±13, p>0.05 RoPE 4±3 vs. 6±2 p>0.05). In multivariable analysis, absence of infarct on neuroimaging was an independent predictor of medical management recommendation by the board (OR 0.05 95% CI 0.01-0.19 p<0.05). Event frequency was low in both cohorts (5.9% vs. 4.8% p>0.05) and were comprised primarily of cardiac arrhythmias (6 atrial fibrillation and 1 ICH in Closure group; 1 TIA and 1 recurrent stroke in medical management group). Excellent functional outcome (mRS 0-1) was similar in both cohorts (66% vs. 71% p>0.05) at 1 year.

Multidisciplinary approach towards PFO closure results in low frequency of complications (recurrent ischemic stroke, ICH and post-PFO closure cardiac arrythmias) and good outcomes. Infarct on neuroimaging predicts closure recommendation by the multidisciplinary board.

Authors/Disclosures
Muhib Khan, MD, FAAN (Mayo Clinic)
PRESENTER
The institution of Dr. Khan has received research support from Mayo Clinic 好色先生 Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Philip M. McCarthy, DO (Spectrum Health) Dr. McCarthy has nothing to disclose.
No disclosure on file
Jiangyong Min, MD (Corewell Health West) Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Malgorzata Miller, MD (Corewell Health) The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial.
Jenny P. Tsai, MD (Cleveland Clinic) Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Tsai has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of NeuroInterventional Surgery.
No disclosure on file
Duane Berkompas (Spectrum Health) No disclosure on file
Nabil Wees, MD (Augusta University) Dr. Wees has nothing to disclose.
Nadeem I. Khan, MD (Spectrum Health) Dr. Khan has nothing to disclose.
Asad Ahrar, MD (Corwell Health) Dr. Ahrar has nothing to disclose.
Elizabeth Evans, NP (Spectrum Health Medical Group) Mrs. Evans has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file